Newly identified enzymes help plants sense elevated CO2 and could lead to water-wise cropsDecember 14, 2009
Plants take in the carbon dioxide they need for photosynthesis through microscopic breathing pores in the surface of leaves. But for each molecule of the gas gained, they lose hundreds of water molecules through these same openings. The pores can tighten to save water when CO2 is abundant, but scientists didn't know how that worked until now.
A team led by Julian Schroeder, professor of biology at the University of California, San Diego, has identified the protein sensors that control the response. Enzymes that react with CO2 cause cells surrounding the opening of the pores to close down they report in the journal Nature Cell Biology online December 13.
The discovery could help to boost the response in plants that do not take full advantage of elevated levels of the gas, Schroeder says. "A lot of plants have a very weak response to CO2. So even though atmospheric CO2 is much higher than it was before the industrial age and is continuing to increase, there are plants that are not capitalizing on that. They're not narrowing their pores, which would allow them to take in CO2, while losing less water," he said. "It could be that with these enzymes, you can improve how efficiently plants use water, while taking in CO2 for photosynthesis. Our data in the lab suggest that the CO2 response can be cranked up."
Plants lose 95 percent of the water they take in to evaporation through these pores, also called stoma. Modifying crops to be more responsive to CO2 could help farmers meet demand for food as competition for water increases. In California, for example, 79 percent of water diverted from streams and rivers or pumped from the ground is used for agriculture according to the California Department of Water Resources.
Schroeder's team identified a pair of proteins that are required for the CO2 response in Arabidopsis, a plant commonly used for genetic analysis. The proteins, enzymes called carbonic anhydrases, split CO2 into bicarbonate and protons. Plants with disabled genes for the enzymes fail to respond to increased CO2 concentrations in the air, losing out on the opportunity to conserve water.
Several types of cells in plant leaves contain carbonic anhydrases, including those responsible for photosynthesis, but Schroeder's team showed that the enzymes work directly within a pair of cells, called guard cells, that control the opening of each breathing pore. By adding normal carbonic anhydrase genes designed to work only in guard cells they were able to restore the CO2-triggered pore-tightening response in mutant plants.
Adding extra copies of the genes to the guard cells actually improved water efficiency, the researchers found. "The guard cells respond to CO2 more vigorously," said Honghong Hu, a post doctoral researcher in Schroeder's lab and co-first author of the report. "For every molecule of CO2 they take in, they lose 44 percent less water."
The action of carbonic anhydrases is specific to changes in CO2, the researchers found. Mutant plants still open their pores in response to blue light, a sign that photosynthesis can begin. And their pores also shut when water is scarce, a response mediated by a plant drought-stress hormone.
Photosynthesis continued normally in the mutants as well, suggesting that altering CO2 sensitivity wouldn't stunt growth - good news if the goal is to engineer drought-resistant crops with robust yields.
But saving water and surviving heat involves a tradeoff for plants: Evaporation of water through the pores also cools the plant, just like sweat cools human beings. If future growing conditions are hotter and drier, as they are predicted to be in some parts of the world, then modifications to the CO2 response will need to be carefully calibrated.
University of California - San Diego
Related Enzymes Current Events and Enzymes News Articles
Study illuminates role of cancer drug decitabine in repairing damaged cells
A Purdue University study sheds light on how cell damage is reversed by the cancer drug decitabine and identifies a potential biomarker that could indicate a patient's stage of cancer and response to treatment.
Engineered softwood could transform pulp, paper and biofuel industries
Scientists today demonstrated the potential for softwoods to process more easily into pulp and paper if engineered to incorporate a key feature of hardwoods.
Scientists X-ray anti-inflammatory drug candidates
Using DESY's ultra bright X-ray source PETRA III, scientists have decoded the molecular and three-dimensional structure of two promising drug candidates from the new group of Spiegelmers for the first time.
Engineering the P450 enzyme to perform new reactions
Enzymes, the micro machines in our cells, can evolve to perform new tasks when confronted with novel situations.
Protein Adseverin identified as key factor driving bone loss in osteoinflammatory disease
Adseverin, a protein found in the body, has been identified as the key driver behind the bone loss associated with the world's most common inflammatory disease: gum disease, or periodontitis.
New signaling pathway discovered in HER2-positive breast cancer, and 2 powerful drug targets
One of the most promising ideas in cancer treatment is to apply a lesson learned in the fight against AIDS (Acquired Immune Deficiency Syndrome): simultaneously attacking a pathological process at different points of weakness can, in some cases, deal a knock-out blow.
Chemists create modular system for placing proteins on membranes
With a tag, an anchor and a cage that can be unlocked with light, chemists have devised a simple, modular system that can locate proteins at the membrane of a cell.
Fighting tuberculosis using the body's natural anti-microbial processes
A new approach to combatting tuberculosis would take advantage of a complex, natural process called autophagy that the human body uses to recycle nutrients, remove damaged cell components, eliminate invading bacteria, and respond to inflammation.
High fidelity: SLU researcher finds keys to genome integrity
Maintaining the stability and the correct sequence of our genetic information is vital to the accurate transmission of our genetic code.
Researchers find new approach to treat drug-resistant HER2-positive breast cancer
Resistance to therapy is a major problem in the cancer field. Even when a treatment initially works, the tumors often find ways around the therapy. Using human cell lines of the HER2-positive breast cancer subtype, researchers from the UNC School of Medicine and UNC Lineberger Comprehensive Cancer Center have detailed the surprising ways in which resistance manifests and how to defeat it before it happens.
More Enzymes Current Events and Enzymes News Articles